Bayer Faces New Yaz Wrongful Death LawsuitMay 12, 2011 | Parker Waichman LLP
Bayer Corporation, already facing more than 6,000 personal injury and wrongful death lawsuits over its Yaz and Yasmin birth control pills, has been named in yet another. Joan Cummins of Hackettstown, New Jersey claims Yaz caused the blood clot that killed her 18-year-old daughter in March 2010.
Yaz and Yasmin both contain drospirenone, a synthetic progestin that may pose a higher risk of blood clots compared to oral contraceptives made with levonorgestrel, an older form of progestin. According to Newsinferno.com, several studies, including two recently published in the British Medical Journal, have found that birth control pills made with drospirenone were associated with a higher risk of dangerous blood clots, including pulmonary embolisms and deep vein thrombosis.
Newsinferno also said that adverse event reports to the FDA involving Yaz or Yasmin include more than 900 cases of pulmonary embolism (blood clots in the lungs), 487 of deep vein thrombosis (clots in the deep veins), and 229 of other blood clots.
It was a pulmonary embolism that killed Cummins’ daughter, Michelle Pfleger, who was a freshman at Elon University in North Carolina when she passed away. Her mother's Yaz wrongful death lawsuit claims that Yaz is a dangerous prescription drug sold without adequate warnings about the risks of serious and fatal injuries.
Many similar Yaz and Yasmin lawsuits have been consolidated in the Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation in the United States District Court for the Southern District of Illinois before Judge David R. Herndon (MDL No. 2100).